Skip to main content
Log in

Final NICE yes for ranibizumab . . .

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. NICE. NICE finds advanced ovarian cancer treatment too expensive with not enough benefit. Media Release : 21 May 2013. Available from: URL: http://www.nice.org.uk

  2. NICE. NICE says yes to ranibizumab for common eye condition. Media Release : 21 May 2013. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Final NICE yes for ranibizumab . . .. PharmacoEcon Outcomes News 679, 10 (2013). https://doi.org/10.1007/s40274-013-0450-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0450-2

Navigation